Come up with a name for your new list and we'll add to it:
Topas Therapeutics raised a round of funding on November 03, 2017. Investors include
Boehringer Ingelheim Venture Fund.
Topas Therapeutics has developed a unique technology for the induction of antigen-specific immune tolerance. This new approach has the potential to treat autoimmune diseases, allergies and drug induce…